Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pregnancy Medication Market

Pregnancy Medication Market Share

Report ID: GMI5385
Published Date: Oct 2022
Report Format: PDF

Download Free Sample

Pregnancy Medication Market Share

Major companies participating in the pregnancy medication industry are

Alkem Laboratories Limited
Piramal Enterprises Limited
F.Hoffman-La Roche Ltd
Pfizer
Dr. Reddy’s Laboratories
Cipla Inc
Alembic Pharmaceuticals Ltd
Lupin Limited
Glenmark Pharmaceuticals Ltd
Viatris Inc. (Mylan Inc.)
Amgen Inc.

These players have been adopting brand acquisitions, mergers, and collaboration as part of their key growth strategy.

For instance, in June 2022, Glenmark Pharmaceuticals Ltd. and its U.S. subsidiary announced the acquisition of Wockhardt Ltd.'s generic interpretations of 4 OTC drugs. The move designated the continued expansion of the firm's over-the-counter business in the U.S., comprising vitamins, minerals, and other products.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for pregnancy medication exceeded USD 33 billion in 2022 and is projected to exhibit around 13% CAGR from 2023 to 2032 owing to the surging incidences of complexities associated with pregnancy and childbirth.

Nutritional supplements segment was worth over USD 16.5 billion in 2022 and is anticipated to amass significant market share by 2032 due to the proven benefits of nutritional supplements in supporting healthy fetal growth and preventing the prospects of neural tube defects.

Retail pharmacy segment is predicted to hold around 28% market share by 2032, driven by the availability of a wide range of health products and customized prescription and treatment at affordable prices.

Notable players in the pregnancy medication MARKET are Alkem Laboratories Limited, Piramal Enterprises Limited, F.Hoffman-La Roche Ltd, Pfizer, Dr. Reddy